Penumbra's Revolutionary PE Treatment Trial Hits 100-Patient Mark, Results Could Transform Blood Clot Care

Penumbra completes enrolment in trial for pulmonary embolism

Penumbra has completed subject enrolment in the multi-centre, randomised controlled trial, STORM-PE, for pulmonary embolism (PE).The post Penumbra completes enrolment in trial for pulmonary embolism appeared first on Medical Device Network.

Penumbra Completes Enrollment for STORM-PE Randomized Controlled Trial

The STORM-PE clinical trial is comparing computer assisted vacuum thrombectomy using Penumbra’s Lightning Flash with anticoagulation in the treatment of acute intermediate-high risk pulmonary embolism

Aventus thrombectomy system gains FDA clearance for PE treatment - Interventional News

Inquis Medical has announced that its Aventus thrombectomy system has received 510(k) clearance from the US Food and Drug Administration (FDA) for an expanded indication to treat pulmonary embolism (PE). The Aventus System is a next-generation mechanical thrombectomy platform developed in close collaboration with physicians to address critical limitations of current technologies. “The FDA’s clearance of the Aventus system marks a major milestone…

Aventus thrombectomy system gains FDA clearance for PE treatment - Cardiovascular News

Inquis Medical has announced that its Aventus thrombectomy system has received 510(k) clearance from the US Food and Drug Administration (FDA) for an expanded indication to treat pulmonary embolism (PE). The Aventus System is a next-generation mechanical thrombectomy platform developed in close collaboration with physicians to address critical limitations of current technologies. “The FDA’s clearance of the Aventus system marks a major milestone…

Penumbra's Revolutionary PE Treatment Trial Hits 100-Patient Mark, Results Could Transform Blood Clot Care

First-of-its-kind RCT evaluates computer-assisted thrombectomy vs. standard care in 100 PE patients. Trial completed ahead of schedule. See potential impact.

Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial

STORM-PE is a first-of-its-kind clinical trial comparing computer assisted vacuum thrombectomy (CAVT™) using Penumbra's Lightning Flash™ with anticoagulation versus anticoagulation alone in the treatment of acute intermediate-high risk pulmonary embolism